Titlebook: Malignancies of the Genitourinary Tract; Rolf Ackermann,Volker Diehl Conference proceedings 1993 Springer-Verlag Berlin Heidelberg 1993 DN

GROG

Immunocytology as a Possible Marker to Identify Patients Who Require Prophylaxisevelop recurrent tumors, even without prophylaxis. Thus, the most important issue in our own and many other studies is: Can those patients who will not develop a recurrent bladder tumor and who therefore do not need prophylactic therapy be reliably identified?

严厉批评

Image Analysis DNA Cytometry of Bladder Cancer the pathologist only, and not on objective or measurable criteria. Therefore, as demonstrated by Ooms et al. [8], it is not surprising that the intra- and interindividual reproducibility of histological grading is poor.

nephritis